Press Release for Early Warning Report Regarding Rakovina Therapeutics Inc.

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW./

VANCOUVER, BC, March 26, 2021 /CNW/ - NewGen Therapeutics, Inc. ("NewGen"), a wholly owned subsidiary of Edison Oncology Holding Corp. ("EOHC"), today announced that on Thursday, March 25, 2021, NewGen acquired ownership of an aggregate of 30,000,000 common shares ("Common Shares") in the capital of Rakovina Therapeutics Inc. (formerly "Vincero Capital Corp.") (the "Company") (TSXV: RKV), a company with a head office at 2201 - 8 Smithe Mews, Vancouver, British Columbia, V6B 0A5.

Pursuant to the terms and conditions of an amended and restated business combination agreement between NewGen and the Company dated March 15, 2021 (the "Business Combination Agreement"), the Common Shares were issued to NewGen in connection with the acquisition by the Company of all of the issued and outstanding shares of Rakovina Therapeutics Inc. ("Subco") by way of a three-cornered amalgamation (the "Qualifying Transaction"), in which: (i) a wholly-owned subsidiary of the Company, 1260541 B.C. Ltd., amalgamated with Subco to form an amalgamated company ("Amalco"); (ii) all issued and outstanding securities of Subco were exchanged for securities of the Company on a 1:1 basis; and (iii) Amalco became a wholly-owned subsidiary of the Company. As a result of the Qualifying Transaction, NewGen was issued an aggregate of 30,000,000 Common Shares, representing approximately 43% of the issued and outstanding Common Shares. As NewGen is a wholly owned subsidiary of EOHC, EOHC and NewGen jointly own and control 30,000,000 Common Shares, representing approximately 43% of the issued and outstanding Common Shares.

NewGen, under the control of EOHC, may from time to time acquire additional securities, dispose of some or all of the existing or additional securities or may continue to hold the securities of the Company. For further information and to obtain a copy of the early warning report filed by NewGen under applicable Canadian securities laws, please see the Company's profile on SEDAR at www.sedar.com.

EOHC is a corporation existing under the laws of the State of Nevada, U.S.A.  NewGen is a corporation existing under the laws of the State of Delaware, U.S.A. The address of EOHC and NewGen is Suite R, 3475 Edison Way, Menlo Park, California, U.S.A., 94025.

SOURCE Rakovina Therapeutics Inc.

Or to obtain a copy of the subject early warning report, please contact: David Hyman, 2201 - 8 Smithe Mews, Vancouver, British Columbia, V6B 0A5, Tel: [phone]